EPIZYME INC (EPZM)

US29428V1044 - Common Stock

1.47  -0.02 (-1.34%)

After market: 1.47 0 (0%)

News Image
2 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Reminds WWE, DRE, MN, and EPZM Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Reminds RFP, ZEN, RDUS, and EPZM Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Image
2 years ago - Halper Sadeh LLP

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ZEN, GRRB, EPZM

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Reminds FSTX, ZEN, RDUS, and EPZM Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Image
2 years ago - Moore Kuehn, PLLC

Moore Kuehn Encourages EPZM, RDUS, OBCI, and CNVY Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

News Image
2 years ago - Halper Sadeh LLP

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ZEN, USAK, EPZM

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - FinancialNewsMedia

Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027

Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent treatment. Factors such as the increasing prevalence and incidence of pancreatic cancer and advancements in molecular biology, development of drugs, and diagnostic technology play a major part in […]

News Image
2 years ago - FinancialNewsMedia.com

Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027

/PRNewswire/ -- Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent treatment. Factors...

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Epizyme, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Epizyme, Inc....

News Image
2 years ago - Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Epizyme, Inc. has obtained a Fair Price in its transaction with Ipsen

/PRNewswire/ -- Ademi LLP is investigating Epizyme (NASDAQ:EPZM) for possible breaches of fiduciary duty and other violations of law in its transaction with...

News Image
2 years ago - InvestorPlace

Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal

Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs.

News Image
2 years ago - InvestorPlace

Why Is Epizyme (EPZM) Stock Up 75% Today?

EPZM stock is jumping higher today on news that Epizyme is being acquired by French pharmaceutical company Ipsen.

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Good morning, trader! We're starting off the week with an overview of the biggest pre-market stock movers for Monday morning!